p53 Family and Cellular Stress Responses in Cancer

p53 is an important tumor suppressor gene, which is stimulated by cellular stress like ionizing radiation, hypoxia, carcinogens, and oxidative stress. Upon activation, p53 leads to cell-cycle arrest and promotes DNA repair or induces apoptosis via several pathways. p63 and p73 are structural homologs of p53 that can act similarly to the protein and also hold functions distinct from p53. Today more than 40 different isoforms of the p53 family members are known. They result from transcription via different promoters and alternative splicing. Some isoforms have carcinogenic properties and mediate resistance to chemotherapy. Therefore, expression patterns of the p53 family genes can offer prognostic information in several malignant tumors. Furthermore, the p53 family constitutes a potential target for cancer therapy. Small molecules (e.g., Nutlins, RITA, PRIMA-1, and MIRA-1 among others) have been objects of intense research interest in recent years. They restore pro-apoptotic wild-type p53 function and were shown to break chemotherapeutic resistance. Due to p53 family interactions small molecules also influence p63 and p73 activity. Thus, the members of the p53 family are key players in the cellular stress response in cancer and are expected to grow in importance as therapeutic targets.

• Publication year

  2014

• Venue

  Frontiers in Oncology

• Publication date

  2014-10-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3389/fonc.2014.00285PMID 25374842PMCID 4204435
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The multifunctional sorting protein PACS-2 regulates SIRT1-mediated deacetylation of p53 to modulate p21-dependent cell-cycle arrest.

  2014cited by this paper
• Mutant p53 in Cancer: New Functions and Therapeutic Opportunities

  2014cited by this paper
• The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.

  2014cited by this paper
• SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis

  2014cited by this paper
• Systemic effects of acute cigarette smoke exposure in mice

  2014cited by this paper
• Role of p73 Dinucleotide Polymorphism in Prostate Cancer and p73 Protein Isoform Balance

  2014cited by this paper
• Resistance acquisition to MDM2 inhibitors.

  2014cited by this paper
• Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents

  2014cited by this paper
• p63 isoforms regulate metabolism of cancer stem cells.

  2014influential reference
• How the TP53 Family Proteins TP63 and TP73 Contribute to Tumorigenesis: Regulators and Effectors

  2014cited by this paper
• Regulated cell death: signaling and mechanisms.

  2014cited by this paper
• Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities

  2014cited by this paper
• Systems biology of death receptor networks: live and let die

  2014cited by this paper
• p53: The barrier to cancer stem cell formation

  2014cited by this paper
• Essential versus accessory aspects of cell death: recommendations of the NCCD 2015

  2014cited by this paper
• After Embedding in Membranes Antiapoptotic Bcl-XL Protein Binds Both Bcl-2 Homology Region 3 and Helix 1 of Proapoptotic Bax Protein to Inhibit Apoptotic Mitochondrial Permeabilization*

  2014cited by this paper
• Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling.

  2014cited by this paper
• p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis

  2013cited by this paper
• Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in TP53 wild‐type ovarian cancer cells

  2013cited by this paper
• Dual Targeting of Wild-Type and Mutant p53 by Small Molecule RITA Results in the Inhibition of N-Myc and Key Survival Oncogenes and Kills Neuroblastoma Cells In Vivo and In Vitro

  2013cited by this paper
• p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice.

  2013cited by this paper
• PRIMA-1Met/APR-246 Displays High Antitumor Activity in Multiple Myeloma By Induction of p73 and Noxa

  2013cited by this paper
• Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia-related patients is rescued by the small compound APR-246/PRIMA-1MET

  2013cited by this paper
• Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers

  2013cited by this paper
• Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6

  2013cited by this paper
• TAp73 knockout mice show morphological and functional nervous system defects associated with loss of p75 neurotrophin receptor

  2013cited by this paper
• Mutant p53 Regulates Dicer through p63-dependent and -independent Mechanisms to Promote an Invasive Phenotype*

  2013cited by this paper
• Transcriptional regulation of human DNA repair genes following genotoxic stress: trigger mechanisms, inducible responses and genotoxic adaptation

  2013cited by this paper
• Prima-1 induces apoptosis in bladder cancer cell lines by activating p53

  2013cited by this paper
• Poly (C)-Binding Protein 1 Regulates p63 Expression through mRNA Stability

  2013cited by this paper
• The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis

  2013cited by this paper
• Danger signalling during cancer cell death: origins, plasticity and regulation

  2013cited by this paper
• p73 haploinsufficiency causes tau hyperphosphorylation and tau kinase dysregulation in mouse models of aging and Alzheimer's disease.

  2013cited by this paper
• p63 regulates glutaminase 2 expression

  2013cited by this paper
• Caspase functions in cell death and disease.

  2013cited by this paper
• Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.

  2013cited by this paper
• Uncovering the role of p53 splice variants in human malignancy: a clinical perspective

  2013cited by this paper
• TAp73 enhances the pentose phosphate pathway and supports cell proliferation

  2013cited by this paper
• The p63 Protein Isoform ΔNp63α Inhibits Epithelial-Mesenchymal Transition in Human Bladder Cancer Cells

  2012cited by this paper
• The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status

  2012cited by this paper
• p63/p73 in the control of cell cycle and cell death.

  2012influential reference
• HuR Is Necessary for Mammary Epithelial Cell Proliferation and Polarity at Least in Part via ΔNp63

  2012cited by this paper
• Small molecules that bind the Mdm2 RING stabilize and activate p53.

  2012cited by this paper
• p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer.

  2012cited by this paper
• Current advances in the synthesis and antitumoral activity of SIRT1-2 inhibitors by modulation of p53 and pro-apoptotic proteins.

  2012cited by this paper
• Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63

  2012cited by this paper
• HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas

  2012influential reference
• The p53 network: cellular and systemic DNA damage responses in aging and cancer.

  2012cited by this paper
• TAp73 depletion accelerates aging through metabolic dysregulation.

  2012cited by this paper
• A "twist box" code of p53 inactivation: twist box: p53 interaction promotes p53 degradation.

  2012cited by this paper
• The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer.

  2012cited by this paper
• Preclinical pharmacokinetics of MI-219, a novel human double minute 2 (HDM2) inhibitor and prediction of human pharmacokinetics.

  2012cited by this paper
• FLASH is essential during early embryogenesis and cooperates with p73 to regulate histone gene transcription

  2012cited by this paper
• Crystal Structures of the DNA-binding Domain Tetramer of the p53 Tumor Suppressor Family Member p73 Bound to Different Full-site Response Elements

  2012cited by this paper
• Pirh2 E3 Ubiquitin Ligase Modulates Keratinocyte Differentiation Through p63

  2012cited by this paper
• An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription

  2011cited by this paper
• Activation of p53 by Nutlin-3a Induces Apoptosis and Cellular Senescence in Human Glioblastoma Multiforme

  2011cited by this paper
• p63, a story of mice and men.

  2011cited by this paper
• New insights into oncogenic stress

  2011cited by this paper
• The cancer stem cell: premises, promises and challenges

  2011cited by this paper
• Mutant p53 gain of function is interwoven into the hallmarks of cancer

  2011cited by this paper
• p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage

  2011cited by this paper
• While p73 is essential, p63 is completely dispensable for the development of the central nervous system

  2011cited by this paper
• Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells

  2011cited by this paper
• Non-hominid TP63 lacks retroviral LTRs but contains a novel conserved upstream exon

  2011cited by this paper
• p63 and p73 Isoform Expression in Non-small Cell Lung Cancer and Corresponding Morphological Normal Lung Tissue

  2011cited by this paper
• Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011influential reference
• The p53 Pathway as a Target in Cancer Therapeutics: Obstacles and Promise

  2011cited by this paper
• p73 in Cancer.

  2011cited by this paper
• MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines

  2011cited by this paper
• p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53

  2011cited by this paper
• The Role of BH3-Only Proteins in Tumor Cell Development, Signaling, and Treatment.

  2011influential reference
• Family friction as ΔNp73 antagonises p73 and p53.

  2011cited by this paper
• Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes

  2011cited by this paper
• p73 as a Pharmaceutical Target for Cancer Therapy

  2011cited by this paper
• A Phase I First-in-Human Pharmacokinetic and Pharmacodynamic Study of Serdemetan in Patients with Advanced Solid Tumors

  2011cited by this paper
• Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

  2011cited by this paper
• Interplay between SIRT proteins and tumour suppressor transcription factors in chemotherapeutic resistance of cancer.

  2011influential reference
• MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro

  2011cited by this paper
• Differential regulation of TP73 isoforms by 1α,25‐dihydroxyvitamin D3 and survivin in human colon and breast carcinomas

  2010influential reference
• Transcription-independent p53 apoptosis: an alternative route to death.

  2010influential reference
• Transcriptional regulation by p53.

  2010cited by this paper
• Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway.

  2010cited by this paper
• Mutant p53 gain-of-function in cancer.

  2010cited by this paper
• RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability

  2010cited by this paper
• Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity in Both p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibiting the Akt Pathway

  2010cited by this paper
• Δ160p53 is a novel N‐terminal p53 isoform encoded by Δ133p53 transcript

  2010cited by this paper
• Chemotherapy‐induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway

  2010cited by this paper
• p63 and p73, the ancestors of p53.

  2010influential reference
• Dominant negative (DeltaN) p63alpha induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways.

  2010cited by this paper
• The regulation of the p53-mediated stress response by MDM2 and MDM4.

  2010cited by this paper
• Delta40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs.

  2010cited by this paper
• The Novel Tryptamine Derivative JNJ-26854165 Induces Wild-Type p53- and E2F1-Mediated Apoptosis in Acute Myeloid and Lymphoid Leukemias

  2010cited by this paper
• Pharmacological reactivation of mutant p53: from protein structure to the cancer patient

  2010cited by this paper
• PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73

  2010influential reference
• Differences in the transactivation domains of p53 family members: a computational study

  2010cited by this paper
• ΔNp73β is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria

  2010cited by this paper
• Differential control of TAp73 and ΔNp73 protein stability by the ring finger ubiquitin ligase PIR2

  2010cited by this paper
• The BCL-2 family reunion.

  2010cited by this paper

• Targeting Oxidative Stress in Carcinogenesis: Oleanolic Acid and Its Molecular Pathways

  2026cites this paper
• Characterizing two subtypes of osteosarcoma using G2M checkpoint-related genes and revealing its immune landscape.

  2026cites this paper
• Molecular switch mediates the glucocorticoid receptor transition from tumor suppressor to oncogene in the prostate

  2026cites this paper
• In vitro and in vivo anticancer efficacy of the combination of Actinomycin D and resveratrol.

  2026cites this paper
• Translational potential of GADD45α: biomarker and therapeutic target in age-associated neurodegeneration and longevity

  2025cites this paper
• Δ133p53α and Δ160p53α isoforms of the tumor suppressor protein p53 exert dominant-negative effect primarily by co-aggregation

  2025cites this paper
• Effects of cyanobacterium Phormidium nigroviride K3 on zebrafish embryos and genomic insights into its toxic potential.

  2025cites this paper
• Targeting p53-p21 signaling to enhance mesenchymal stem cell regenerative potential

  2025cites this paper
• Combined Schisandrin B and Temozolomide Treatment Induces Mitochondrial Apoptosis in Glioma Cells.

  2025cites this paper
• Proline‐ and Serine‐Rich Coiled‐Coil 1 Predicts an Unfavorable Prognosis and Exhibits Oncogenic Activities in Breast Cancer

  2025cites this paper
• Modifiable Risk Factors Including Self-Perceived Stress for Breast Cancer in Hong Kong: A Case-Control Study of 10 757 Subject

  2025cites this paper
• Gut microbiome-mediated epigenetic modifications in gastric cancer: a comprehensive multiomics analysis

  2025cites this paper
• Propisochlor disrupts cardiovascular and neural development through apoptotic and oxidative pathways in zebrafish.

  2025cites this paper
• Assessment of cytotoxic, apoptotic, enzyme inhibitory, and antioxidant properties, and phytochemical characterization of ethanolic extract from Cionura erecta

  2025cites this paper
• The Molecular Interplay Between p53-Mediated Ferroptosis and Non-Coding RNAs in Cancer

  2025cites this paper
• Brominated flame retardant BDE-99 promotes apoptosis by intrinsic mitochondrial pathway in rat liver

  2025cites this paper
• Development of an innovative approach for early diagnosis of cervical cancer using TCR-like antibodies targeting HPV18 E6 and E7 peptides

  2025cites this paper
• Using MUC2 mucin producing tumorigenic human goblet-like cells to uncover functional properties of the mucus barrier

  2025cites this paper
• The Internal Ribosome Entry Site in Circular RNAs.

  2025cites this paper
• Unlocking the Gateway: The Spatio-Temporal Dynamics of the p53 Family Driven by the Nuclear Pores and Its Implication for the Therapeutic Approach in Cancer

  2024cites this paper
• Assessment and process optimization of high throughput biofabrication of immunocompetent breast cancer model for drug screening applications

  2024cites this paper
• Paraptosis—A Distinct Pathway to Cell Death

  2024cites this paper
• Understanding the molecular regulatory mechanisms of autophagy in lung disease pathogenesis

  2024cites this paper
• The Role of Cytokines in Activation of Tumour-promoting Pathways and Emergence of Cancer Drug Resistance.

  2024cites this paper
• Vascular architecture regulates mesenchymal stromal cell heterogeneity via P53-PDGF signaling in the mouse incisor.

  2024cites this paper
• The difference of transcriptome of HPV-infected patients contributes more to the occurrence of cervical cancer than the mutations of E6 and E7 genes in HPV16

  2024cites this paper
• miRNAs Involvement in Modulating Signalling Pathways Involved in Ros-Mediated Oxidative Stress in Melanoma

  2024cites this paper
• Effects of thymoquinone and the curcumin analog EF-24 on the activity of the enzyme paraoxonase-1 in human glioblastoma cells U87MG

  2024cites this paper
• Integrative Analysis of Transcriptional Regulation of the ATG4D, an Autophagy-Related Gene, Using JASPAR and STRING databases.

  2024cites this paper
• Targeting the p53-p21 axis in liver cancer: Linking cellular senescence to tumor suppression and progression.

  2024cites this paper
• Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection

  2024cites this paper
• Antioxidant Systems as Modulators of Ferroptosis: Focus on Transcription Factors

  2024cites this paper
• A novel amphiphilic squalene-based compound with open-chain polyethers reduces malignant melanoma metastasis in-vitro and in-vivo

  2024cites this paper
• Roles of Mutant TP53 Gene in Cancer Development and Progression

  2024cites this paper
• Evening primrose oil enriched with gamma linolenic acid and D/L-alpha tocopherol acetate attenuated carbon tetrachloride-induced hepatic injury model in male rats via TNF-α, IL-1β, and IL-6 pathway

  2024cites this paper
• Differential Gene Expression in Human Fibroblasts Simultaneously Exposed to Ionizing Radiation and Simulated Microgravity

  2024cites this paper
• Natural products targeting inflammation-related metabolic disorders: A comprehensive review

  2023cites this paper
• Simultaneous Inhibition of Mcl-1 and Bcl-2 Induces Synergistic Cell Death in Hepatocellular Carcinoma

  2023cites this paper
• The p53 Family of Transcription Factors Represses the Alpha- fetoprotein Gene Expression in Hepatocellular Carcinoma.

  2023cites this paper
• Metformin and Aspirin: Anticancer effects on A549 and PC3 cancer cells and the mechanisms of action.

  2023cites this paper
• Transactivation by partial function P53 family mutants is increased by the presence of G-quadruplexes at a promoter site.

  2023cites this paper
• Examining the Role of Chronic Stress in Cancer Progression and Metastasis: p53 as a Potential Mechanism

  2023cites this paper
• Small Change - Big Consequence: The Impact of C15-C16 Double Bond in a D‑ring of Estrone on Estrogen Receptor Activity.

  2023cites this paper
• UBE2V2 promotes metastasis by regulating EMT and predicts a poor prognosis in lung adenocarcinoma

  2023cites this paper
• Highly Similar Tetramerization Domains from the p53 Protein of Different Mammalian Species Possess Varying Biophysical, Functional and Structural Properties

  2023influential citation
• Differential effects of pesticides on dioxin receptor signaling and p53 activation

  2023cites this paper
• Fibrin Stiffness Regulates Phenotypic Plasticity of Metastatic Breast Cancer Cells

  2023cites this paper
• Haberlea rhodopensis alcohol extract normalizes stress-responsive transcription of the human TP53 gene

  2023cites this paper
• Pyrimido[4,5-b]indole derivatives bearing 1,2,4-oxadiazole moiety as MDM2 inhibitor candidates in cancer treatment.

  2023cites this paper
• T cell immunotherapy for cervical cancer: challenges and opportunities

  2023cites this paper
• Attenuating Effect of Spirulina (Arthrospira platensis) against Di (2-ethylhexyl) Phthalate Induced Toxicity in Wistar Rat

  2023cites this paper
• p53 and HuR combinatorially control the biphasic dynamics of microRNA-125b in response to genotoxic stress

  2023cites this paper
• Cancer-derived mutation in the OGA stalk domain promotes cell malignancy through dysregulating PDLIM7 and p53

  2023cites this paper
• The Important Role of Protein Kinases in the p53 Sestrin Signaling Pathway

  2023cites this paper
• The Role of Genetic Polymorphisms in Differentiated Thyroid Cancer: A 2023 Update

  2023cites this paper
• The Dual Roles of MAGE-C2 in p53 Ubiquitination and Cell Proliferation Through E3 Ligases MDM2 and TRIM28

  2022cites this paper
• Role of non-coding RNAs in radiosensitivity of colorectal cancer: A narrative review

  2022cites this paper
• A potent estrogen receptor and microtubule specific purine-benzothiazole-based fluorescent molecular probe induces apoptotic death of breast cancer cells

  2022cites this paper
• Cruciferous vegetables as a treasure of functional foods bioactive compounds: Targeting p53 family in gastrointestinal tract and associated cancers

  2022influential citation
• Indole-3-Carbinol, a Phytochemical Aryl Hydrocarbon Receptor-Ligand, Induces the mRNA Overexpression of UBE2L3 and Cell Proliferation Arrest

  2022cites this paper
• Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins

  2022cites this paper
• Dicoma anomala Enhances Phthalocyanine Mediated Photodynamic Therapy in MCF-7 Breast Cancer Cells

  2022cites this paper
• Genomics of Human Papillomavirus-induced Cervical Cancer

  2022cites this paper
• Li–Fraumeni syndrome in Tunisian carriers with different and rare tumor phenotype: genotype–phenotype correlation

  2022cites this paper
• Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma

  2022cites this paper
• Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challenges

  2022cites this paper
• Magnetoelectric core–shell CoFe2O4@BaTiO3 nanorods: their role in drug delivery and effect on multidrug resistance pump activity in vitro

  2022cites this paper
• GOF Mutant p53 in Cancers: A Therapeutic Challenge

  2022cites this paper
• Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma

  2022cites this paper
• DDDT_A_308713 3845..3862

  2021cites this paper
• Comparative Evaluation of Apoptosis Induction Using Needles, Bark, and Pollen Extracts and Essential Oils of Pinus eldarica in Lung Cancer Cells

  2021cites this paper
• Insights on the disruption of the complex between human positive coactivator 4 and p53 by small molecules.

  2021cites this paper
• Identification of Highly Frequent TP53 Germline Variations in a Cohort of Head and Neck Cancer Cases

  2021cites this paper
• Preconditioning with Near-Infrared Irradiation to Enhance the Irreversible Electroporation Efficiency in HeLa Cells

  2021cites this paper
• The Jieduan-Niwan (JDNW) Formula Ameliorates Hepatocyte Apoptosis: A Study of the Inhibition of E2F1-Mediated Apoptosis Signaling Pathways in Acute-on-Chronic Liver Failure (ACLF) Using Rats

  2021cites this paper
• Genome-Wide Identification of Autophagy Prognostic Signature in Pancreatic Cancer

  2021cites this paper
• p73 as a Tissue Architect

  2021cites this paper
• Puma, noxa, p53, and p63 differentially mediate stress pathway induced apoptosis

  2021cites this paper
• Linking Oxidative Stress and DNA Damage to Changes in the Expression of Extracellular Matrix Components

  2021cites this paper
• Evaluation of 40-bp deletion/insertion polymorphism of mdm2 and 16-bp deletion/insertion polymorphism of p53 gene in patients with lymphoma in a Persian population

  2021cites this paper
• Y2O3 Nanoparticles and X-ray Radiation-Induced Effects in Melanoma Cells

  2021cites this paper
• The Potential of 9,10-Anthraquinone in Inhibiting Human Cancer Cells Growth

  2021cites this paper
• Anoikis Resistance and Development in Prostate Cancer: The Possible Role of HPV/EBV Coinfection

  2021cites this paper
• Cancer cell line for mechanisms of clinical anticancer drug resistance

  2021cites this paper
• The Role of the CREB Protein Family Members and the Related Transcription Factors in Radioresistance Mechanisms

  2021cites this paper
• Histological Severity Risk Factors Identification in Juvenile-Onset Recurrent Respiratory Papillomatosis: How Immunohistochemistry and AI Algorithms Can Help?

  2021cites this paper
• LRRC8A influences the growth of gastric cancer cells via the p53 signaling pathway

  2021cites this paper
• TRPV1 Activation Promotes β-arrestin2 Interaction with the Ribosomal Biogenesis Machinery in the Nucleolus: Implications for p53 Regulation and Neurite Outgrowth

  2021cites this paper
• DNA damage response and repair in pancreatic cancer development and therapy.

  2021cites this paper
• Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells—Relevance for Understanding (Germ Cell) Tumorigenesis

  2021cites this paper
• Genetic and methylation status of CDKN2A (p14ARF / p16INK4A) and TP53 genes in recurrent respiratory papillomatosis.

  2021cites this paper
• A Newly Defined Pyroptosis-Related Gene Signature for the Prognosis of Bladder Cancer

  2021cites this paper
• Noncanonical roles of p53 in cancer stemness and their implications in sarcomas.

  2021cites this paper
• Biocompatibility and cytotoxicity in vitro of surface-functionalized drug-loaded spinel ferrite nanoparticles

  2021cites this paper
• Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies

  2021cites this paper
• Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer

  2021cites this paper
• p53-mediated G1 arrest requires the induction of both p21 and Killin in human colon cancer cells

  2021cites this paper
• The first pancreatic neuroendocrine tumor in Li-Fraumeni syndrome: a case report

  2020cites this paper
• Recent Synthetic Approaches towards Small Molecule Reactivators of p53

  2020cites this paper
• Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer

  2020cites this paper